Literature DB >> 23428724

[ALPPS (Associated Liver Partition and Portal vein ligation for Staged hepatectomy) -- faster and greater growth of liver].

Oszkár Hahn1, Ibolyka Dudás, Péter Pajor, Tamás Györke, Csaba Korom, Attila Zsirka-Klein, Péter Kupcsulik, László Harsányi.   

Abstract

CASE REPORT: 75 years old female patient was referred with large, multifocal colorectal liver metastasis. Prior to this consultation she received chemotherapies of various protocols and series. Liver metastasis, however, increased at about 3 times of the original size during the 5 months of the oncological treatment. A right extended hepatectomy was planned to remove the tumor, but the residual liver (FLR) was found to be too small. Portal occlusion technique was necessary to induce the hypertrophy of the FLR. Due to rapid tumor progression we decided to perform the first ALPPS (PVL + in situ split) procedure in Hungary. After a very fast (9 days) and significant (94%) hypertrophy of the FLR the planned liver resection was successfully performed.

Entities:  

Mesh:

Year:  2013        PMID: 23428724     DOI: 10.1556/MaSeb.66.2013.1.3

Source DB:  PubMed          Journal:  Magy Seb        ISSN: 0025-0295


  3 in total

Review 1.  Current position of ALPPS in the surgical landscape of CRLM treatment proposals.

Authors:  Marcello Donati; Gregor A Stavrou; Karl J Oldhafer
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

2.  Did the International ALPPS Meeting 2015 Have an Impact on Daily Practice? The Hamburg Barmbek Experience of 58 Cases.

Authors:  Gregor A Stavrou; Marcello Donati; Mohammad H Fard-Aghaie; Martin Zeile; Tessa M Huber; Axel Stang; Karl J Oldhafer
Journal:  Visc Med       Date:  2017-11-30

3.  Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver.

Authors:  András Fülöp; Attila Szijártó; László Harsányi; András Budai; Damján Pekli; Diána Korsós; Ildikó Horváth; Noémi Kovács; Kinga Karlinger; Domokos Máthé; Krisztián Szigeti
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.